• Corpus ID: 88515947

Quantifying the recency of HIV infection using multiple longitudinal biomarkers

  title={Quantifying the recency of HIV infection using multiple longitudinal biomarkers},
  author={Loumpiana Koulai and Anne M Presanis and Gary Murphy and Barbara Suligoi and Daniela De Angelis},
  journal={arXiv: Applications},
Knowledge of the time at which an HIV-infected individual seroconverts, when the immune system starts responding to HIV infection, plays a vital role in the design and implementation of interventions to reduce the impact of the HIV epidemic. A number of biomarkers have been developed to distinguish between recent and long-term HIV infection, based on the antibody response to HIV. To quantify the recency of infection at an individual level, we propose characterising the growth of such biomarkers… 

Figures and Tables from this paper

Estimating HIV incidence from multiple sources of data
This thesis develops novel statistical methodology for estimating the incidence and the prevalence of Human Immunodeficiency Virus using routinely collected surveillance data using age-dependent and age-independent back-calculation to achieve the joint estimation of age-and-time dependent HIV incidence and diagnosis rates.


Estimation of the Distribution of Infection Times Using Longitudinal Serological Markers of HIV: Implications for the Estimation of HIV Incidence
This work proposes a model based on the repeated measurements of virological markers of seroconversion for the marker trajectory that can be used for estimating the distribution of infection times for newly HIV diagnosed subjects reported in a HIV surveillance system.
Hierarchical Bayes Models for the Progression of HIV Infection Using Longitudinal CD4 T-Cell Numbers
This work model longitudinal series of CD4 T-cells as a marker of disease progression for persons infected with the human immunodeficiency virus for a sample of 327 subjects in the San Francisco Men's Health Study and develops an approach to Bayesian model choice and individual prediction.
Estimating the distribution of the window period for recent HIV infections: A comparison of statistical methods
Two statistical methods are compared for estimating the mean and distribution of a window period using data on repeated measurements of an antibody biomarker from a cohort of HIV seroconverters, using the Avidity Index as a proxy.
Estimation of time since exposure for a prevalent cohort.
The accuracy of imputation is further validated by comparisons of imputations-based estimates of AIDS incubation distribution in the seroprevalent subcohort with more direct estimates obtained from the seroincident sub cohort.
Estimation of time since infection using longitudinal disease-marker data.
A method to estimate the usually unknown time since infection for individuals infected with human immunodeficiency virus type 1 (HIV-1) was proposed and it was suggested that the underlying mathematical model tends to overestimate short times since infection and underestimate long timesSince infection.
Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’
Results highlight that assuming a single continuous sojourn in the ‘recent’ state can produce substantial bias and show the relationships between MDRI estimation performance and the number of subjects, inter-visit intervals, missed visits, loss to follow-up, and aspects of biomarker signal and noise.
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
The determination of ω with more data and new methodology suggests that ω of the BED-CEIA varies between different subtypes and/or populations, which may affect incidence estimates in various studies.
Bivariate modelling of longitudinal measurements of two human immunodeficiency type 1 disease progression markers in the presence of informative drop‐outs
The joint multivariate random‐effects model is extended to model simultaneously the CD4 cell and viral load data while adjusting for informative drop‐outs due to disease progression or death while evaluated and compared with simpler approaches in a simulation study.
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
Results from this first independent evaluation of five incidence assays suggest that viral load will be a particularly valuable supplementary marker among virally suppressed patients, and suggest the need for further optimization.
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting “Recent” HIV Infection and Calculating Population Incidence
The data suggest that with additional interpretive analysis of the band intensities using an algorithm and cutoff, the Geenius HIV-1/2 Supplemental Assay can be used to identify recent HIV infection in addition to confirming the presence of HIV- 1 and HIV-2 antibodies.